SlideShare a Scribd company logo
Aarkstore.com announces, The Latest market research report is available in
its vast collection:

Cholangiocellular Hepatoma – Pipeline Review, H2 2012


http://www.aarkstore.com/reports/Cholangiocellular-Hepatoma-Pipeline-
Review-H2-2012-220600.html


RSS link of Global Markets Direct
http://www.aarkstore.com/feeds/Global-Markets-Direct.xml




Summary

Global Markets Direct’s, Cholangiocellular Hepatoma - Pipeline Review, H2 2012,
provides an overview of the Cholangiocellular Hepatoma therapeutic pipeline. This
report provides information on the therapeutic development for Cholangiocellular
Hepatoma, complete with latest updates, and special features on late-stage and
discontinued projects. It also reviews key players involved in the therapeutic
development for Cholangiocellular Hepatoma. Cholangiocellular Hepatoma -
Pipeline Review, H2 2012 is built using data and information sourced from Global
Markets Direct’s proprietary databases, Company/University websites, SEC filings,
investor presentations and featured press releases from company/university sites
and industry-specific third party sources, put together by Global Markets Direct’s
team.

Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Cholangiocellular Hepatoma.
- A review of the Cholangiocellular Hepatoma products under development by
companies and universities/research institutes based on information derived from
company and industry-specific sources.
- Coverage of products based on various stages of development ranging from
discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined
therapeutics.
- Coverage of the Cholangiocellular Hepatoma pipeline on the basis of route of
administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description,
mechanism of action and research & development progress.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Table of contents:

List of Tables 3
List of Figures 3
Introduction 4
Global Markets Direct Report Coverage 4
Cholangiocellular Hepatoma Overview 5
Therapeutics Development 6
An Overview of Pipeline Products for Cholangiocellular Hepatoma 6
Late Stage Products 8
Comparative Analysis 8
Cholangiocellular Hepatoma Therapeutics – Products under Investigation by
Universities/Institutes 9
Assessment by Combination Products 10
Assessment by Molecule Type 11
Drug Profiles 13
Cisplatin + Gemcitabine + Epirubicin - Drug Profile 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
Appendix 14
Methodology 14
Coverage 14
Secondary Research 14
Primary Research 14
Expert Panel Validation 14
Contact Us 15
Disclaimer 15



List of Figures

List of Tables are also include.




For more related Reports Plz follow The link:

Pipeline Review, H2 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H2
2012&PubId=&pagenum=1




Cholangiocellular Hepatoma – Pipeline Review, H2 2012

Hormone Refractory Breast Cancer – Pipeline Review, H2 2012

Muscle Invasive Bladder Cancer (MIBC) – Pipeline Review, H2 2012

Refractory Multiple Myeloma – Pipeline Review, H2 2012

Epithelial Ovarian Cancer – Pipeline Review, H2 2012

Neuro Endocrine (Carcinoid) Carcinoma – Pipeline Review, H2 2012

B-Cell Leukemia – Pipeline Review, H2 2012

Malignant Neoplasms – Pipeline Review, H2 2012
Recurrent Malignant Glioma – Pipeline Review, H2 2012

Endobronchial Cancer – Pipeline Review, H2 2012

Leiomyosarcoma – Pipeline Review, H2 2012

Transitional Cell Cancer (Urothelial Cell Cancer) – Pipeline Review, H2 2012

Esophageal Tumor – Pipeline Review, H2 2012

Malignant Pleural Mesothelioma – Pipeline Review, H2 2012




Search More Reports Related to This Category :


Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1


You can also request for sample page of above mention reports on
sample@aarkstore.com




For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

More Related Content

What's hot

Mixed dyslipidemia – pipeline review, h1 2012
Mixed dyslipidemia – pipeline review, h1 2012Mixed dyslipidemia – pipeline review, h1 2012
Mixed dyslipidemia – pipeline review, h1 2012
Rose088
 
Amyloidosis – pipeline review, h2 2012
Amyloidosis – pipeline review, h2 2012Amyloidosis – pipeline review, h2 2012
Amyloidosis – pipeline review, h2 2012
Rose088
 
Keratitis – pipeline review, h1 2012
Keratitis – pipeline review, h1 2012Keratitis – pipeline review, h1 2012
Keratitis – pipeline review, h1 2012
Rose088
 
Acute renal failure (arf) (acute kidney injury)
Acute renal failure (arf) (acute kidney injury)Acute renal failure (arf) (acute kidney injury)
Acute renal failure (arf) (acute kidney injury)
Rose088
 
Refractory multiple myeloma – pipeline review, h2 2012
Refractory multiple myeloma – pipeline review, h2 2012Refractory multiple myeloma – pipeline review, h2 2012
Refractory multiple myeloma – pipeline review, h2 2012
Rose088
 
Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012
Rose088
 
Proteo, inc. – product pipeline review – 2012
Proteo, inc. – product pipeline review – 2012Proteo, inc. – product pipeline review – 2012
Proteo, inc. – product pipeline review – 2012
Rose088
 
S.l.a. pharma ag – product pipeline review – 2012
S.l.a. pharma ag – product pipeline review – 2012S.l.a. pharma ag – product pipeline review – 2012
S.l.a. pharma ag – product pipeline review – 2012
Rose088
 
Viro statics, srl – product pipeline review – 2012
Viro statics, srl – product pipeline review – 2012Viro statics, srl – product pipeline review – 2012
Viro statics, srl – product pipeline review – 2012
Rose088
 
Macro genics, inc. – product pipeline review – 2012
Macro genics, inc. – product pipeline review – 2012Macro genics, inc. – product pipeline review – 2012
Macro genics, inc. – product pipeline review – 2012
Rose088
 
Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Rose088
 
Viventia biotechnologies inc. – product pipeline review – 2012
Viventia biotechnologies inc. – product pipeline review – 2012Viventia biotechnologies inc. – product pipeline review – 2012
Viventia biotechnologies inc. – product pipeline review – 2012
Rose088
 
Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012
Rose088
 
Reata pharmaceuticals, inc. – product pipeline review – 2012
Reata pharmaceuticals, inc. – product pipeline review – 2012Reata pharmaceuticals, inc. – product pipeline review – 2012
Reata pharmaceuticals, inc. – product pipeline review – 2012
Rose088
 
7 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 20127 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 2012
Rose088
 
Hereditary angioedema (hae) – pipeline review, h2 2012
Hereditary angioedema (hae) – pipeline review, h2 2012Hereditary angioedema (hae) – pipeline review, h2 2012
Hereditary angioedema (hae) – pipeline review, h2 2012
Rose088
 
Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012
Rose088
 
Zydus cadila healthcare limited – product pipeline review – 2012
Zydus cadila healthcare limited – product pipeline review – 2012Zydus cadila healthcare limited – product pipeline review – 2012
Zydus cadila healthcare limited – product pipeline review – 2012
Rose088
 
Geron corporation – product pipeline review – 2012
Geron corporation – product pipeline review – 2012Geron corporation – product pipeline review – 2012
Geron corporation – product pipeline review – 2012
Rose088
 
Evaluation of Caprolactam Production Processes
Evaluation of Caprolactam Production ProcessesEvaluation of Caprolactam Production Processes
Evaluation of Caprolactam Production Processes
Intratec Solutions
 

What's hot (20)

Mixed dyslipidemia – pipeline review, h1 2012
Mixed dyslipidemia – pipeline review, h1 2012Mixed dyslipidemia – pipeline review, h1 2012
Mixed dyslipidemia – pipeline review, h1 2012
 
Amyloidosis – pipeline review, h2 2012
Amyloidosis – pipeline review, h2 2012Amyloidosis – pipeline review, h2 2012
Amyloidosis – pipeline review, h2 2012
 
Keratitis – pipeline review, h1 2012
Keratitis – pipeline review, h1 2012Keratitis – pipeline review, h1 2012
Keratitis – pipeline review, h1 2012
 
Acute renal failure (arf) (acute kidney injury)
Acute renal failure (arf) (acute kidney injury)Acute renal failure (arf) (acute kidney injury)
Acute renal failure (arf) (acute kidney injury)
 
Refractory multiple myeloma – pipeline review, h2 2012
Refractory multiple myeloma – pipeline review, h2 2012Refractory multiple myeloma – pipeline review, h2 2012
Refractory multiple myeloma – pipeline review, h2 2012
 
Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012
 
Proteo, inc. – product pipeline review – 2012
Proteo, inc. – product pipeline review – 2012Proteo, inc. – product pipeline review – 2012
Proteo, inc. – product pipeline review – 2012
 
S.l.a. pharma ag – product pipeline review – 2012
S.l.a. pharma ag – product pipeline review – 2012S.l.a. pharma ag – product pipeline review – 2012
S.l.a. pharma ag – product pipeline review – 2012
 
Viro statics, srl – product pipeline review – 2012
Viro statics, srl – product pipeline review – 2012Viro statics, srl – product pipeline review – 2012
Viro statics, srl – product pipeline review – 2012
 
Macro genics, inc. – product pipeline review – 2012
Macro genics, inc. – product pipeline review – 2012Macro genics, inc. – product pipeline review – 2012
Macro genics, inc. – product pipeline review – 2012
 
Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012
 
Viventia biotechnologies inc. – product pipeline review – 2012
Viventia biotechnologies inc. – product pipeline review – 2012Viventia biotechnologies inc. – product pipeline review – 2012
Viventia biotechnologies inc. – product pipeline review – 2012
 
Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012
 
Reata pharmaceuticals, inc. – product pipeline review – 2012
Reata pharmaceuticals, inc. – product pipeline review – 2012Reata pharmaceuticals, inc. – product pipeline review – 2012
Reata pharmaceuticals, inc. – product pipeline review – 2012
 
7 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 20127 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 2012
 
Hereditary angioedema (hae) – pipeline review, h2 2012
Hereditary angioedema (hae) – pipeline review, h2 2012Hereditary angioedema (hae) – pipeline review, h2 2012
Hereditary angioedema (hae) – pipeline review, h2 2012
 
Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012
 
Zydus cadila healthcare limited – product pipeline review – 2012
Zydus cadila healthcare limited – product pipeline review – 2012Zydus cadila healthcare limited – product pipeline review – 2012
Zydus cadila healthcare limited – product pipeline review – 2012
 
Geron corporation – product pipeline review – 2012
Geron corporation – product pipeline review – 2012Geron corporation – product pipeline review – 2012
Geron corporation – product pipeline review – 2012
 
Evaluation of Caprolactam Production Processes
Evaluation of Caprolactam Production ProcessesEvaluation of Caprolactam Production Processes
Evaluation of Caprolactam Production Processes
 

Similar to Cholangiocellular hepatoma – pipeline review, h2 2012

Penile cancer pipeline review, q3 2011
Penile cancer   pipeline review, q3 2011Penile cancer   pipeline review, q3 2011
Penile cancer pipeline review, q3 2011
linda3395
 
Bacteremia – pipeline review, h1 2012
Bacteremia – pipeline review, h1 2012Bacteremia – pipeline review, h1 2012
Bacteremia – pipeline review, h1 2012
Rose088
 
Arrhythmias pipeline review, h1 2015
Arrhythmias   pipeline review, h1 2015Arrhythmias   pipeline review, h1 2015
Arrhythmias pipeline review, h1 2015
Ambikabasa
 
Pique therapeutics – product pipeline review – 2012
Pique therapeutics – product pipeline review – 2012Pique therapeutics – product pipeline review – 2012
Pique therapeutics – product pipeline review – 2012
Rose088
 
Congestive heart failure (heart failure) – pipeline
Congestive heart failure (heart failure) – pipelineCongestive heart failure (heart failure) – pipeline
Congestive heart failure (heart failure) – pipeline
Rose088
 
Ziopharm oncology, inc. – product pipeline review – 2012
Ziopharm oncology, inc. – product pipeline review – 2012Ziopharm oncology, inc. – product pipeline review – 2012
Ziopharm oncology, inc. – product pipeline review – 2012
Rose088
 
Shire plc – product pipeline review – 2012
Shire plc – product pipeline review – 2012Shire plc – product pipeline review – 2012
Shire plc – product pipeline review – 2012
Rose088
 
Travelers diarrhea pipeline review, h1 2015
Travelers diarrhea   pipeline review, h1 2015Travelers diarrhea   pipeline review, h1 2015
Travelers diarrhea pipeline review, h1 2015
Ambikabasa
 
Coronary vasospasm pipeline review, q3 2011
Coronary vasospasm   pipeline review, q3 2011Coronary vasospasm   pipeline review, q3 2011
Coronary vasospasm pipeline review, q3 2011
linda3395
 
Cytokinetics, incorporated – product pipeline review – 2012
Cytokinetics, incorporated – product pipeline review – 2012Cytokinetics, incorporated – product pipeline review – 2012
Cytokinetics, incorporated – product pipeline review – 2012
Rose088
 
Nuon therapeutics, inc. – product pipeline review – 2012
Nuon therapeutics, inc. – product pipeline review – 2012Nuon therapeutics, inc. – product pipeline review – 2012
Nuon therapeutics, inc. – product pipeline review – 2012
Rose088
 
Rhabdomyosarcoma pipeline review, h1 2015
Rhabdomyosarcoma   pipeline review, h1 2015Rhabdomyosarcoma   pipeline review, h1 2015
Rhabdomyosarcoma pipeline review, h1 2015
Ambikabasa
 
Pro strakan group plc – product pipeline review – 2012
Pro strakan group plc – product pipeline review – 2012Pro strakan group plc – product pipeline review – 2012
Pro strakan group plc – product pipeline review – 2012
Rose088
 
Effimune – product pipeline review – 2012
Effimune – product pipeline review – 2012Effimune – product pipeline review – 2012
Effimune – product pipeline review – 2012
Rose088
 
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Rose088
 
Alchemia limited – product pipeline review – 2012
Alchemia limited – product pipeline review – 2012Alchemia limited – product pipeline review – 2012
Alchemia limited – product pipeline review – 2012
Rose088
 
Pulmonary Arterial Hypertension - Pipeline Review, H2 2017
Pulmonary Arterial Hypertension - Pipeline Review, H2 2017Pulmonary Arterial Hypertension - Pipeline Review, H2 2017
Pulmonary Arterial Hypertension - Pipeline Review, H2 2017
Market Research Reports, Inc.
 
Sym bio pharmaceuticals limited – product pipeline review – 2012
Sym bio pharmaceuticals limited – product pipeline review – 2012Sym bio pharmaceuticals limited – product pipeline review – 2012
Sym bio pharmaceuticals limited – product pipeline review – 2012
Rose088
 
Paroxysmal nocturnal hemoglobinuria pipeline review, h1 2015
Paroxysmal nocturnal hemoglobinuria   pipeline review, h1 2015Paroxysmal nocturnal hemoglobinuria   pipeline review, h1 2015
Paroxysmal nocturnal hemoglobinuria pipeline review, h1 2015
Ambikabasa
 
Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012
Rose088
 

Similar to Cholangiocellular hepatoma – pipeline review, h2 2012 (20)

Penile cancer pipeline review, q3 2011
Penile cancer   pipeline review, q3 2011Penile cancer   pipeline review, q3 2011
Penile cancer pipeline review, q3 2011
 
Bacteremia – pipeline review, h1 2012
Bacteremia – pipeline review, h1 2012Bacteremia – pipeline review, h1 2012
Bacteremia – pipeline review, h1 2012
 
Arrhythmias pipeline review, h1 2015
Arrhythmias   pipeline review, h1 2015Arrhythmias   pipeline review, h1 2015
Arrhythmias pipeline review, h1 2015
 
Pique therapeutics – product pipeline review – 2012
Pique therapeutics – product pipeline review – 2012Pique therapeutics – product pipeline review – 2012
Pique therapeutics – product pipeline review – 2012
 
Congestive heart failure (heart failure) – pipeline
Congestive heart failure (heart failure) – pipelineCongestive heart failure (heart failure) – pipeline
Congestive heart failure (heart failure) – pipeline
 
Ziopharm oncology, inc. – product pipeline review – 2012
Ziopharm oncology, inc. – product pipeline review – 2012Ziopharm oncology, inc. – product pipeline review – 2012
Ziopharm oncology, inc. – product pipeline review – 2012
 
Shire plc – product pipeline review – 2012
Shire plc – product pipeline review – 2012Shire plc – product pipeline review – 2012
Shire plc – product pipeline review – 2012
 
Travelers diarrhea pipeline review, h1 2015
Travelers diarrhea   pipeline review, h1 2015Travelers diarrhea   pipeline review, h1 2015
Travelers diarrhea pipeline review, h1 2015
 
Coronary vasospasm pipeline review, q3 2011
Coronary vasospasm   pipeline review, q3 2011Coronary vasospasm   pipeline review, q3 2011
Coronary vasospasm pipeline review, q3 2011
 
Cytokinetics, incorporated – product pipeline review – 2012
Cytokinetics, incorporated – product pipeline review – 2012Cytokinetics, incorporated – product pipeline review – 2012
Cytokinetics, incorporated – product pipeline review – 2012
 
Nuon therapeutics, inc. – product pipeline review – 2012
Nuon therapeutics, inc. – product pipeline review – 2012Nuon therapeutics, inc. – product pipeline review – 2012
Nuon therapeutics, inc. – product pipeline review – 2012
 
Rhabdomyosarcoma pipeline review, h1 2015
Rhabdomyosarcoma   pipeline review, h1 2015Rhabdomyosarcoma   pipeline review, h1 2015
Rhabdomyosarcoma pipeline review, h1 2015
 
Pro strakan group plc – product pipeline review – 2012
Pro strakan group plc – product pipeline review – 2012Pro strakan group plc – product pipeline review – 2012
Pro strakan group plc – product pipeline review – 2012
 
Effimune – product pipeline review – 2012
Effimune – product pipeline review – 2012Effimune – product pipeline review – 2012
Effimune – product pipeline review – 2012
 
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
 
Alchemia limited – product pipeline review – 2012
Alchemia limited – product pipeline review – 2012Alchemia limited – product pipeline review – 2012
Alchemia limited – product pipeline review – 2012
 
Pulmonary Arterial Hypertension - Pipeline Review, H2 2017
Pulmonary Arterial Hypertension - Pipeline Review, H2 2017Pulmonary Arterial Hypertension - Pipeline Review, H2 2017
Pulmonary Arterial Hypertension - Pipeline Review, H2 2017
 
Sym bio pharmaceuticals limited – product pipeline review – 2012
Sym bio pharmaceuticals limited – product pipeline review – 2012Sym bio pharmaceuticals limited – product pipeline review – 2012
Sym bio pharmaceuticals limited – product pipeline review – 2012
 
Paroxysmal nocturnal hemoglobinuria pipeline review, h1 2015
Paroxysmal nocturnal hemoglobinuria   pipeline review, h1 2015Paroxysmal nocturnal hemoglobinuria   pipeline review, h1 2015
Paroxysmal nocturnal hemoglobinuria pipeline review, h1 2015
 
Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012
 

More from Rose088

India wellness industry outlook 2016 robust growth in alternative
India wellness industry outlook 2016   robust growth in alternativeIndia wellness industry outlook 2016   robust growth in alternative
India wellness industry outlook 2016 robust growth in alternative
Rose088
 
India waste management and recycling market outlook to 2016
India waste management and recycling market outlook to 2016India waste management and recycling market outlook to 2016
India waste management and recycling market outlook to 2016
Rose088
 
Downstream processing in biopharmaceuticals adoption
Downstream processing in biopharmaceuticals   adoptionDownstream processing in biopharmaceuticals   adoption
Downstream processing in biopharmaceuticals adoption
Rose088
 
Incyte corporation – product pipeline review – 2012
Incyte corporation – product pipeline review – 2012Incyte corporation – product pipeline review – 2012
Incyte corporation – product pipeline review – 2012
Rose088
 
Chinese markets for industrial lubricants
Chinese markets for industrial lubricantsChinese markets for industrial lubricants
Chinese markets for industrial lubricants
Rose088
 
Mumbai
MumbaiMumbai
Mumbai
Rose088
 
Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012
Rose088
 
Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012
Rose088
 
Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012Rose088
 
Emerging power markets in south east asia
Emerging power markets in south east asiaEmerging power markets in south east asia
Emerging power markets in south east asia
Rose088
 
Cloud computing in pharmaceutical research
Cloud computing in pharmaceutical researchCloud computing in pharmaceutical research
Cloud computing in pharmaceutical research
Rose088
 
Mundipharma international limited – product pipeline review – 2012
Mundipharma international limited – product pipeline review – 2012Mundipharma international limited – product pipeline review – 2012
Mundipharma international limited – product pipeline review – 2012
Rose088
 
Wockhardt limited – product pipeline review – 2012
Wockhardt limited – product pipeline review – 2012Wockhardt limited – product pipeline review – 2012
Wockhardt limited – product pipeline review – 2012
Rose088
 

More from Rose088 (13)

India wellness industry outlook 2016 robust growth in alternative
India wellness industry outlook 2016   robust growth in alternativeIndia wellness industry outlook 2016   robust growth in alternative
India wellness industry outlook 2016 robust growth in alternative
 
India waste management and recycling market outlook to 2016
India waste management and recycling market outlook to 2016India waste management and recycling market outlook to 2016
India waste management and recycling market outlook to 2016
 
Downstream processing in biopharmaceuticals adoption
Downstream processing in biopharmaceuticals   adoptionDownstream processing in biopharmaceuticals   adoption
Downstream processing in biopharmaceuticals adoption
 
Incyte corporation – product pipeline review – 2012
Incyte corporation – product pipeline review – 2012Incyte corporation – product pipeline review – 2012
Incyte corporation – product pipeline review – 2012
 
Chinese markets for industrial lubricants
Chinese markets for industrial lubricantsChinese markets for industrial lubricants
Chinese markets for industrial lubricants
 
Mumbai
MumbaiMumbai
Mumbai
 
Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012
 
Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012
 
Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012
 
Emerging power markets in south east asia
Emerging power markets in south east asiaEmerging power markets in south east asia
Emerging power markets in south east asia
 
Cloud computing in pharmaceutical research
Cloud computing in pharmaceutical researchCloud computing in pharmaceutical research
Cloud computing in pharmaceutical research
 
Mundipharma international limited – product pipeline review – 2012
Mundipharma international limited – product pipeline review – 2012Mundipharma international limited – product pipeline review – 2012
Mundipharma international limited – product pipeline review – 2012
 
Wockhardt limited – product pipeline review – 2012
Wockhardt limited – product pipeline review – 2012Wockhardt limited – product pipeline review – 2012
Wockhardt limited – product pipeline review – 2012
 

Recently uploaded

Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 

Recently uploaded (20)

Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 

Cholangiocellular hepatoma – pipeline review, h2 2012

  • 1. Aarkstore.com announces, The Latest market research report is available in its vast collection: Cholangiocellular Hepatoma – Pipeline Review, H2 2012 http://www.aarkstore.com/reports/Cholangiocellular-Hepatoma-Pipeline- Review-H2-2012-220600.html RSS link of Global Markets Direct http://www.aarkstore.com/feeds/Global-Markets-Direct.xml Summary Global Markets Direct’s, Cholangiocellular Hepatoma - Pipeline Review, H2 2012, provides an overview of the Cholangiocellular Hepatoma therapeutic pipeline. This report provides information on the therapeutic development for Cholangiocellular Hepatoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cholangiocellular Hepatoma. Cholangiocellular Hepatoma - Pipeline Review, H2 2012 is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - A snapshot of the global therapeutic scenario for Cholangiocellular Hepatoma. - A review of the Cholangiocellular Hepatoma products under development by companies and universities/research institutes based on information derived from
  • 2. company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the Cholangiocellular Hepatoma pipeline on the basis of route of administration and molecule type. - Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress. - Key discontinued pipeline projects. - Latest news and deals relating to the products. Table of contents: List of Tables 3 List of Figures 3 Introduction 4 Global Markets Direct Report Coverage 4 Cholangiocellular Hepatoma Overview 5 Therapeutics Development 6 An Overview of Pipeline Products for Cholangiocellular Hepatoma 6 Late Stage Products 8 Comparative Analysis 8 Cholangiocellular Hepatoma Therapeutics – Products under Investigation by Universities/Institutes 9 Assessment by Combination Products 10 Assessment by Molecule Type 11 Drug Profiles 13 Cisplatin + Gemcitabine + Epirubicin - Drug Profile 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 Appendix 14 Methodology 14 Coverage 14 Secondary Research 14 Primary Research 14
  • 3. Expert Panel Validation 14 Contact Us 15 Disclaimer 15 List of Figures List of Tables are also include. For more related Reports Plz follow The link: Pipeline Review, H2 2012 http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H2 2012&PubId=&pagenum=1 Cholangiocellular Hepatoma – Pipeline Review, H2 2012 Hormone Refractory Breast Cancer – Pipeline Review, H2 2012 Muscle Invasive Bladder Cancer (MIBC) – Pipeline Review, H2 2012 Refractory Multiple Myeloma – Pipeline Review, H2 2012 Epithelial Ovarian Cancer – Pipeline Review, H2 2012 Neuro Endocrine (Carcinoid) Carcinoma – Pipeline Review, H2 2012 B-Cell Leukemia – Pipeline Review, H2 2012 Malignant Neoplasms – Pipeline Review, H2 2012
  • 4. Recurrent Malignant Glioma – Pipeline Review, H2 2012 Endobronchial Cancer – Pipeline Review, H2 2012 Leiomyosarcoma – Pipeline Review, H2 2012 Transitional Cell Cancer (Urothelial Cell Cancer) – Pipeline Review, H2 2012 Esophageal Tumor – Pipeline Review, H2 2012 Malignant Pleural Mesothelioma – Pipeline Review, H2 2012 Search More Reports Related to This Category : Pharmaceuticals and Healthcare http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1 You can also request for sample page of above mention reports on sample@aarkstore.com For More details Plz do contact : Aarkstore Enterprise Lavanya Phone:08149852585 Email: enquiry@aarkstore.com